CaixaBank, S.A.’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-352
Closed -$14K – 305
2016
Q4
$14K Buy
+352
New +$15K ﹤0.01% 190

Other funds holding BIB

CaixaBank, S.A.'s BIB Position: Q1 2017 in Review

CaixaBank, S.A. sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2017, closing a stake of 352 shares — an estimated $14K sold.

CaixaBank, S.A. first reported a position in BIB in Q4 2016 and held it in 1 quarter. The position peaked at $14K in Q4 2016. 28 funds tracked by Wall St. Rank hold BIB as of Q1 2017.

  • CaixaBank, S.A. reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2017 after selling out during the quarter.
  • CaixaBank, S.A. sold 352 ProShares Ultra NASDAQ Biotechnology shares in Q1 2017, an estimated $14K.
  • CaixaBank, S.A. first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2016 and held it in 1 quarter.
  • CaixaBank, S.A.'s ProShares Ultra NASDAQ Biotechnology position peaked at $14K in Q4 2016.
  • 28 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2017.

Based on CaixaBank, S.A.'s 13F filing for Q1 2017, filed 16 Nov 2026.